Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.
about
Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in MelanomasIn vivo delivery of antisense MORF oligomer by MORF/carrier streptavidin nanoparticles.Affinity enhancement pretargeting: synthesis and testing of a 99mTc-labeled bivalent MORFHuman islet cell MORF/cMORF pretargeting in a xenogeneic murine transplant modelRadiolabeling of MAG3-morpholino oligomers with 188Re at high labeling efficiency and specific radioactivity for tumor pretargeting.Further investigations of morpholino pretargeting in mice--establishing quantitative relations in tumorSuccessful radiotherapy of tumor in pretargeted mice by 188Re-radiolabeled phosphorodiamidate morpholino oligomer, a synthetic DNA analogue.Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice.Identification of high-affinity VEGFR3-binding peptides through a phage-displayed random peptide library.Labeling biomolecules with radiorhenium: a review of the bifunctional chelators.Quantitative Correlation of in Vivo Properties with in Vitro Assay Results: The in Vitro Binding of a Biotin-DNA Analogue Modifier with Streptavidin Predicts the in Vivo Avidin-Induced Clearability of the Analogue-Modified Antibody.MO tripeptide diastereomers (M=99/99mTc, Re): models to identify the structure of 99mTc peptide targeted radiopharmaceuticals.An improved method for covalently conjugating morpholino oligomers to antitumor antibodiesAn experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effectorAnti-sense oligonucleotide labeled with technetium-99m using hydrazinonictinamide derivative and N-hydroxysuccinimidyl S-acetylmercaptoacetyltriglycline: a comparison of radiochemical behaviors and biological properties.Pretargeting CWR22 prostate tumor in mice with MORF-B72.3 antibody and radiolabeled cMORF.Synthesis and in vitro characterization of a dendrimer-MORF conjugate for amplification pretargeting.Investigation of four (99m)Tc-labeled bacteriophages for infection-specific imaging.A Brief Review of Chelators for Radiolabeling Oligomers.
P2860
Q28550308-80B14442-93A3-4FEE-ABE0-DC32FEAC20B4Q33905151-3EC8A5CF-D906-4BF0-9474-1B46A3D54CCCQ34039426-BEE837E3-F995-4516-8EE3-3B5F682FE3C6Q35028182-5522A0CF-0217-4D2A-87D9-FE5DD54471BBQ35060365-06BD841B-D1D3-4F74-8F85-DEDD203B411CQ35063676-51BC163A-598C-4AA2-B4DF-8E12C797985AQ35063681-039DFBF5-A105-4808-841B-D7DD7F58C4BEQ35659208-F4293171-D0FA-4D24-9E34-717120FCCC8EQ35703718-396A2B3E-3AD7-4889-B7E7-4EF15CDCA515Q35942576-3585C852-5AEA-447F-8617-E9F0654A7E9DQ36458382-EBF7EB39-13E9-4CA4-9D79-EB4C12A018FFQ36501804-FE368AEE-2A9C-4197-BEA0-CB68B256EF2EQ36865885-EBF95455-EEAC-470D-9ADC-A644415A21CAQ37154201-6A4544A2-AE2F-4AAE-B531-F01A81A87C63Q37245505-304E0160-18DC-4F12-BF55-5C8344257FC7Q38297700-CCF80D0E-C8DA-4D83-BE79-5060DEE5C2CEQ39958380-C41D95A5-F32B-4FE9-B525-0A4C04AABBC7Q42133096-ED9A9766-43B1-429E-A229-F6293888A813Q55426154-4ADCDC36-FAD4-471D-B013-5489F873F043
P2860
Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.
@en
type
label
Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.
@en
prefLabel
Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.
@en
P2093
P1476
Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA.
@en
P2093
Hnatowich DJ
Mardirossian G
Rusckowski M
Winnard P Jr
P304
P356
10.1016/S0969-8051(97)00027-9
P577
1997-07-01T00:00:00Z